tranexamic acid has been researched along with Coagulation, Disseminated Intravascular in 50 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 7.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| "We clarified the role of fibrinolysis in tissue-factor (TF)-induced rat disseminated intravascular coagulation (DIC) using tranexamic acid (TA)." | 7.72 | Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. ( Asakura, H; Miyamoto, K; Morishita, E; Nakao, S; Sano, Y; Yamazaki, M, 2004) |
| "We examined the role of coagulation and fibrinolysis in lipopolysaccharide (LPS) induced disseminated intravascular coagulation (DIC) in rats, studying their contribution to fibrin deposition and organ failure in rats with LPS-induced DIC by concurrent administration of low molecular weight heparin (LMWH) with or without tranexamic acid (TA)." | 7.72 | Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. ( Asakura, H; Miyamoto, K; Mizutani, T; Morishita, E; Nakao, S; Omote, M; Ontachi, Y; Sano, Y; Takami, A; Yamazaki, M; Yoshida, T, 2004) |
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 5.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| "An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency." | 5.39 | [Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013) |
| "The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established." | 5.34 | Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007) |
| "Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm." | 5.33 | Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005) |
| "Tranexamic acid was extremely well tolerated in this newborn." | 5.28 | Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. ( Bernstein, M; Hanna, BD, 1989) |
| " It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia." | 4.91 | Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Anand, V; Martí-Carvajal, AJ; Solà, I, 2015) |
| " It is not possible to determine whether human activated protein C, recombinant human soluble thrombomodulin, tranexamic acid and dermatan sulphate are effective or harmful for patients presenting with DIC related to acute or chronic leukemia." | 4.87 | Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia. ( Cardona, AF; Martí-Carvajal, AJ; Simancas, D, 2011) |
| "In cases of placental abruption complicated with disseminated intravascular coagulation, intrapartum administration of coagulation factors can simultaneously promote effective labor and correct hypofibrinogenemia, enabling minimally invasive vaginal delivery." | 3.80 | Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report. ( Baba, K; Era, S; Honda, M; Matsunaga, S; Seki, H; Takai, Y, 2014) |
| " To control the hemorrhagic diathesis, we commenced combination therapy for DIC with danaparoid (1,250 Ux2/day, intravenously (IV)) and tranexamic acid (0." | 3.73 | Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid. ( Asakura, H; Matsui, O; Nakao, S; Omote, M; Ontachi, Y; Yoshida, T, 2005) |
| " We present a case of postmenopausal bleeding, because of chronic DIC, which resulted from aortic aneurysm and was managed with replacement blood products and tranexamic acid." | 3.72 | Postmenopausal bleeding due to chronic DIC. ( Bollapragada, SS; Garg, M; McFarlane, T, 2004) |
| "We clarified the role of fibrinolysis in tissue-factor (TF)-induced rat disseminated intravascular coagulation (DIC) using tranexamic acid (TA)." | 3.72 | Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. ( Asakura, H; Miyamoto, K; Morishita, E; Nakao, S; Sano, Y; Yamazaki, M, 2004) |
| "We examined the role of coagulation and fibrinolysis in lipopolysaccharide (LPS) induced disseminated intravascular coagulation (DIC) in rats, studying their contribution to fibrin deposition and organ failure in rats with LPS-induced DIC by concurrent administration of low molecular weight heparin (LMWH) with or without tranexamic acid (TA)." | 3.72 | Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid. ( Asakura, H; Miyamoto, K; Mizutani, T; Morishita, E; Nakao, S; Omote, M; Ontachi, Y; Sano, Y; Takami, A; Yamazaki, M; Yoshida, T, 2004) |
| " Although disseminated intravascular coagulation could not be totally excluded as an alternative mechanism, excessive fibrinolysis was confirmed as the pathogenic cause by the prompt response to the administration of tranexamic acid." | 3.67 | Hypofibrinogenemia due to increased fibrinolysis in two patients with acute promyelocytic leukemia. ( Chan, GT; Chan, TK; Chan, V, 1984) |
| "Whereas in DIC associated with trauma, since balance between coagulation and fibrinolysis collapses drastically in a short period, both anticoagulantion therapy and antifibrinolytic therapy can be utilized depending on clinical conditions." | 2.53 | [Anti DIC therapy]. ( Sakamoto, Y; Yahata, M, 2016) |
| "The optimal treatment of aortic dissection-related DIC remains controversial." | 1.72 | Management of disseminated intravascular coagulation after thoracic endovascular aortic repair of type B aortic dissection: a case report. ( Lai, J; Liu, H; Liu, Y, 2022) |
| "The onset of acute traumatic coagulopathy in trauma patients exacerbates hemorrhaging and dramatically increases mortality." | 1.48 | Computational Model for Hyperfibrinolytic Onset of Acute Traumatic Coagulopathy. ( Brummel-Ziedins, K; Buoni, M; Cohen, M; Orfeo, T; Petzold, L; Wu, S; Wu, TB, 2018) |
| "The management of chronic disseminated intravascular coagulation (DIC) caused by aortic dissection has not yet been established." | 1.46 | Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years. ( Adachi, T; Gatate, Y; Kawamura, A; Masaki, N; Namba, T; Sato, A; Yada, H; Yasuda, R, 2017) |
| "An 82-year-old female with a history of aortic dissection was admitted to our hospital for evaluation of thrombocytopenia and a bleeding tendency." | 1.39 | [Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection]. ( Hirano, T; Morikawa, K; Tsuda, H; Tsuji, T; Yamasaki, H, 2013) |
| "The current therapeutic strategy for disseminated intravascular coagulation (DIC) is limited to control of the underlying disease, and methods for the effective management of DIC have not been established." | 1.34 | Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis. ( Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H, 2007) |
| "Chronic disseminated intravascular coagulation (DIC) is a well-known complication of aortic aneurysm." | 1.33 | Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm. ( Arahata, M; Asakura, H; Hayashi, T; Kadohira, Y; Maekawa, M; Minami, S; Morishita, E; Nakao, S; Ontachi, Y; Saito, M; Yamazaki, M, 2005) |
| "Tranexamic acid was extremely well tolerated in this newborn." | 1.28 | Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants. ( Bernstein, M; Hanna, BD, 1989) |
| "Fibrinolysis was inhibited by intravenous injection of AMCA and thrombin was infused into the jugular vein, giving rise to heavy intravascular fibrin deposition in the kidneys." | 1.25 | Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride. ( Gerdin, B; Rammer, L, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (30.00) | 18.7374 |
| 1990's | 8 (16.00) | 18.2507 |
| 2000's | 11 (22.00) | 29.6817 |
| 2010's | 13 (26.00) | 24.3611 |
| 2020's | 3 (6.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Liu, Y | 1 |
| Lai, J | 1 |
| Benhamou, D | 1 |
| Keita, H | 1 |
| Ducloy-Bouthors, AS | 1 |
| Yamada, S | 1 |
| Asakura, H | 8 |
| Gatate, Y | 1 |
| Masaki, N | 1 |
| Sato, A | 1 |
| Yasuda, R | 1 |
| Namba, T | 1 |
| Yada, H | 1 |
| Kawamura, A | 1 |
| Adachi, T | 1 |
| Hattesen, AL | 1 |
| Berg, HK | 1 |
| Folkersen, L | 1 |
| Hvas, AM | 1 |
| Wu, TB | 1 |
| Wu, S | 1 |
| Buoni, M | 1 |
| Orfeo, T | 1 |
| Brummel-Ziedins, K | 1 |
| Cohen, M | 1 |
| Petzold, L | 1 |
| Tsuji, T | 1 |
| Morikawa, K | 1 |
| Hirano, T | 1 |
| Yamasaki, H | 1 |
| Tsuda, H | 1 |
| Engelbrecht, S | 1 |
| Wood, EM | 1 |
| Cole-Sinclair, MF | 1 |
| Cole, E | 1 |
| Davenport, R | 1 |
| Schlitter, MC | 1 |
| Rühl, H | 1 |
| Thiesler, T | 1 |
| Penner, AH | 1 |
| Berens, C | 1 |
| Wolf, D | 1 |
| Mayer, K | 1 |
| Schwameis, M | 1 |
| Thaler, J | 1 |
| Schober, A | 1 |
| Schörgenhofer, C | 1 |
| Kulinna-Cosentini, C | 1 |
| Laggner, A | 1 |
| Röggla, M | 1 |
| Jilma, B | 1 |
| Honda, M | 1 |
| Matsunaga, S | 1 |
| Era, S | 1 |
| Takai, Y | 1 |
| Baba, K | 1 |
| Seki, H | 1 |
| Martí-Carvajal, AJ | 2 |
| Anand, V | 1 |
| Solà, I | 1 |
| Revollo, JY | 1 |
| Cuffy, MC | 1 |
| Witte, DP | 1 |
| Paterno, F | 1 |
| Alloway, RR | 1 |
| Woodle, ES | 1 |
| Yahata, M | 1 |
| Sakamoto, Y | 1 |
| Kimura, SI | 1 |
| Odawara, J | 1 |
| Aoki, T | 1 |
| Yamakura, M | 1 |
| Takeuchi, M | 2 |
| Watanabe, Y | 1 |
| Matsue, K | 2 |
| Colucci, G | 1 |
| Alberio, L | 1 |
| Jahns, M | 1 |
| Keller, P | 1 |
| Steiner, S | 1 |
| Rüsges-Wolter, I | 1 |
| Lämmle, B | 1 |
| Simancas, D | 1 |
| Cardona, AF | 1 |
| Bollapragada, SS | 1 |
| Garg, M | 1 |
| McFarlane, T | 1 |
| Sano, Y | 3 |
| Yamazaki, M | 5 |
| Morishita, E | 5 |
| Miyamoto, K | 4 |
| Nakao, S | 6 |
| Omote, M | 4 |
| Yoshida, T | 4 |
| Ontachi, Y | 5 |
| Mizutani, T | 2 |
| Kaneda, M | 1 |
| Takami, A | 2 |
| Arahata, M | 2 |
| Kadohira, Y | 2 |
| Maekawa, M | 2 |
| Hayashi, T | 2 |
| Saito, M | 1 |
| Minami, S | 1 |
| Matsui, O | 1 |
| Martínez Rodríguez, E | 1 |
| Mato, M | 1 |
| Otero, J | 1 |
| Ferri, JR | 1 |
| Gonzálvez, A | 1 |
| Torres, LM | 1 |
| Takahashi, Y | 1 |
| Koseki, M | 1 |
| Asada, N | 1 |
| Uryu, H | 1 |
| Sabato, AF | 1 |
| Foti, A | 1 |
| De Cosmo, G | 1 |
| Bondoli, A | 1 |
| Chan, TK | 1 |
| Chan, GT | 1 |
| Chan, V | 1 |
| Ståhl, E | 1 |
| Rammer, L | 2 |
| Uchiba, M | 1 |
| Okajima, K | 1 |
| Murakami, K | 1 |
| Okabe, H | 1 |
| Okamoto, S | 2 |
| Okada, Y | 2 |
| Katsaros, D | 1 |
| Grundfest-Broniatowski, S | 1 |
| Meijer, K | 1 |
| Smid, WM | 1 |
| Geerards, S | 1 |
| van der Meer, J | 1 |
| Cremer, H | 1 |
| Schulte am Esch, J | 1 |
| Pannewig, R | 1 |
| Etzel, S | 1 |
| Kondo, M | 1 |
| Yoshikawa, T | 1 |
| Takemura, S | 1 |
| Yokoe, N | 1 |
| Kawai, K | 1 |
| Masuda, M | 1 |
| Sakuragawa, N | 1 |
| Takahashi, K | 1 |
| Hoshiyama, M | 1 |
| Jimbo, C | 1 |
| Matsuoka, M | 1 |
| Prentice, CR | 1 |
| Gerdin, B | 1 |
| Tomikawa, M | 1 |
| Wanaka, K | 1 |
| Hijikata-Okunomiya, A | 1 |
| Katsuura, Y | 1 |
| Sugawara, T | 1 |
| Okuda, M | 1 |
| Yamaguchi, Y | 1 |
| Endo, K | 1 |
| Yoshinaga, K | 1 |
| Takada, A | 1 |
| Takada, Y | 1 |
| Mori, T | 1 |
| Sakaguchi, S | 1 |
| Carthew, P | 1 |
| Dorman, BM | 1 |
| Edwards, RE | 1 |
| Albronda, T | 1 |
| Gökemeyer, JD | 1 |
| van Haeflen, TW | 1 |
| Tomeoku, M | 1 |
| Nakase, T | 1 |
| Morita, K | 1 |
| Katou, M | 1 |
| Eriksson, M | 1 |
| Saldeen, T | 2 |
| Hanna, BD | 1 |
| Bernstein, M | 1 |
| Páramo, JA | 1 |
| Cuesta, B | 1 |
| Aranda, A | 1 |
| Rocha, E | 1 |
| Wegener, T | 1 |
| Wallin, R | 1 |
| Bottari, M | 1 |
| Donati, L | 1 |
| Gagnatelli, G | 1 |
7 reviews available for tranexamic acid and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Topics: Anticoagulants; Autoantibodies; Betacoronavirus; Blood Proteins; Cerebrovascular Disorders; Contrain | 2020 |
Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations.
Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Anticoagulants; Antifibrinolytic | 2021 |
[Drowning-induced hyperfibrinolytic disseminated intravascular coagulation].
Topics: Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Humans; Near Drowning; Thrombelasto | 2017 |
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula | 2015 |
[Anti DIC therapy].
Topics: Anticoagulants; Antifibrinolytic Agents; Antithrombins; Benzamidines; Disseminated Intravascular Coa | 2016 |
Treatment for disseminated intravascular coagulation in patients with acute and chronic leukemia.
Topics: Acute Disease; Anticoagulants; Chronic Disease; Dermatan Sulfate; Disseminated Intravascular Coagula | 2011 |
Indications for antifibrinolytic therapy.
Topics: Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Disorders; Disseminated Intrav | 1975 |
43 other studies available for tranexamic acid and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
Management of disseminated intravascular coagulation after thoracic endovascular aortic repair of type B aortic dissection: a case report.
Topics: Aged; Anticoagulants; Aortic Aneurysm, Thoracic; Aortic Dissection; Blood Vessel Prosthesis Implanta | 2022 |
Tranexamic Acid Controlled Chronic Disseminated Intravascular Coagulation Associated with Aortic Dissection and Patent False Lumen for Three Years.
Topics: Aged; Antifibrinolytic Agents; Aortic Aneurysm; Aortic Dissection; Chronic Disease; Disseminated Int | 2017 |
Computational Model for Hyperfibrinolytic Onset of Acute Traumatic Coagulopathy.
Topics: Acute Disease; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Models, Cardiovascular; | 2018 |
[Effective treatment with tranexamic acid for chronic disseminated intravascular coagulation associated with aortic dissection].
Topics: Aged, 80 and over; Antifibrinolytic Agents; Aortic Dissection; Chronic Disease; Disseminated Intrava | 2013 |
Clinical transfusion practice update: haemovigilance, complications, patient blood management and national standards.
Topics: Acute Lung Injury; Anticoagulants; Antifibrinolytic Agents; Australia; Blood Transfusion; Clinical P | 2013 |
Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most?
Topics: Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Fibrinogen; Hemorrhage; Humans; Tra | 2015 |
Paraneoplastic disseminated intravascular coagulation caused by splenic littoral cell angioma.
Topics: Blood Component Transfusion; Chest Pain; Combined Modality Therapy; Disseminated Intravascular Coagu | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
Intrapartum anti-disseminated intravascular coagulation therapy leading to successful vaginal delivery following intrauterine fetal death caused by placental abruption: a case report.
Topics: Abruptio Placentae; Adult; Antifibrinolytic Agents; Coagulants; Delivery, Obstetric; Disseminated In | 2014 |
Case Report: Hemolytic Anemia Following Deceased Donor Renal Transplantation Associated With Tranexamic Acid Administration for Disseminated Intravascular Coagulation.
Topics: Aged; Anemia, Hemolytic; Antifibrinolytic Agents; Diabetes Mellitus, Type 2; Disseminated Intravascu | 2015 |
Use of tranexamic acid for disseminated intravascular coagulation with excessive fibrinolysis associated with aortic dissection in a patient with chronic renal failure.
Topics: Aged; Aortic Aneurysm; Disseminated Intravascular Coagulation; Fibrinolysis; Humans; Kidney Failure, | 2009 |
Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
Topics: alpha-2-Antiplasmin; Amyloidosis; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; F | 2009 |
Postmenopausal bleeding due to chronic DIC.
Topics: Aged; Aortic Aneurysm; Blood Transfusion; Chronic Disease; Disseminated Intravascular Coagulation; F | 2004 |
Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid.
Topics: Animals; Disseminated Intravascular Coagulation; Fibrinolysis; Hemostasis; Male; Rats; Rats, Wistar; | 2004 |
Significance of decreased plasma D-dimer levels following lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Topics: Animals; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Disseminated Intravascular Coagulat | 2004 |
Beneficial effect of low-molecular-weight heparin against lipopolysaccharide-induced disseminated intravascular coagulation in rats is abolished by coadministration of tranexamic acid.
Topics: Animals; Anticoagulants; Blood Coagulation; Disseminated Intravascular Coagulation; Drug Interaction | 2004 |
Effect of combined therapy of danaparoid sodium and tranexamic acid on chronic disseminated intravascular coagulation associated with abdominal aortic aneurysm.
Topics: Anticoagulants; Antifibrinolytic Agents; Aortic Aneurysm, Abdominal; Chondroitin Sulfates; Dermatan | 2005 |
Kasabach-Merritt syndrome associated with giant liver hemangioma: the effect of combined therapy with danaparoid sodium and tranexamic acid.
Topics: Adult; Antifibrinolytic Agents; Blood Proteins; Chondroitin Sulfates; Dermatan Sulfate; Disseminated | 2005 |
[Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
Topics: Adult; Aminocaproic Acid; Antiphospholipid Syndrome; Aprotinin; Blood Coagulation Tests; Blood Loss, | 2006 |
No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Topics: Animals; Antifibrinolytic Agents; Cytokines; Disseminated Intravascular Coagulation; Hemostatics; In | 2006 |
Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
Topics: Acute Disease; Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents; Antithrom | 2007 |
[Coagulative changes in gynecologic surgery. Clinical and therapeutic evaluation].
Topics: Adult; Aged; Anesthesia; Aprotinin; Blood Coagulation Disorders; Disseminated Intravascular Coagulat | 1980 |
Hypofibrinogenemia due to increased fibrinolysis in two patients with acute promyelocytic leukemia.
Topics: Adult; Afibrinogenemia; Antibiotics, Antineoplastic; Blood Coagulation Tests; Diagnosis, Differentia | 1984 |
Effect of unilateral ureteral occlusion on fibrin deposition in the kidney and renal blood flow during intravascular coagulation in rat.
Topics: Animals; Disseminated Intravascular Coagulation; Female; Fibrin; Kidney; Kidney Glomerulus; Rats; Ra | 1983 |
Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
Topics: Amino Acid Chloromethyl Ketones; Animals; Binding Sites; Bronchoalveolar Lavage Fluid; Capillary Per | 1997 |
Successful management of visceral Klippel-Trenaunay-Weber syndrome with the antifibrinolytic agent tranexamic acid (cyclocapron): a case report.
Topics: Adult; Antifibrinolytic Agents; Blood Coagulation Tests; Colon, Sigmoid; Disseminated Intravascular | 1998 |
Hyperfibrinogenolysis in disseminated adenocarcinoma.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; alpha-2-Antiplasmin; Antifibrinolytic Agents; Brain Ischemia | 1998 |
[Experimental observations in rabbits with pulmonary hyalin membranes (author's transl)].
Topics: Animals; Blood Coagulation Factors; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinol | 1978 |
Hemorrhagic necrosis of the intestinal mucosa associated with disseminated intravascular coagulation.
Topics: Animals; Blood Coagulation Factors; Complement System Proteins; Disseminated Intravascular Coagulati | 1978 |
Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemia.
Topics: Acute Disease; Animals; Aprotinin; Blood Coagulation; Chromatography, Gel; Disseminated Intravascula | 1976 |
Protection against the impairment of renal function after intravascular coagulation in the rat kidney by increased ingestion of sodium chloride.
Topics: Acute Kidney Injury; Animals; Diet; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrinol | 1975 |
Patho-physiological studies on lactic acid-induced pulmonary thrombosis in rat. I. Effect of heparin, acetylsalicylic acid, urokinase and tranexamic acid.
Topics: Animals; Aspirin; Blood Coagulation; Disseminated Intravascular Coagulation; Fibrinolysis; Heparin; | 1975 |
A finding of highly selective synthetic inhibitor of plasma kallikrein; its action to bradykinin generation, intrinsic coagulation and experimental DIC.
Topics: Animals; Blood Coagulation; Bradykinin; Disease Models, Animal; Disseminated Intravascular Coagulati | 1992 |
Successful treatment with tranexamic acid for severe bleeding in acute promyelocytic leukemia.
Topics: Adult; Disseminated Intravascular Coagulation; Female; Hemorrhage; Humans; Leukemia, Promyelocytic, | 1992 |
Prevention of severe bleeding by tranexamic acid in a patient with disseminated intravascular coagulation.
Topics: Aged; alpha-Macroglobulins; Aorta, Abdominal; Aortic Aneurysm; Cyclohexanecarboxylic Acids; Dissemin | 1990 |
Increased susceptibility of aged rats to haemorrhage and intravascular hypercoagulation following endotoxin administered in a generalized Shwartzman regime.
Topics: Aging; Animals; Depression, Chemical; Disease Susceptibility; Disseminated Intravascular Coagulation | 1991 |
Transient acute renal failure due to tranexaminic acid therapy for diffuse intravascular coagulation.
Topics: Acute Kidney Injury; Aged; Disseminated Intravascular Coagulation; Humans; Male; Tranexamic Acid | 1991 |
[Chronic disseminated intravascular coagulation due to abdominal true aneurysm in two cases--effect of anti-platelet and anti-fibrinolytic therapy].
Topics: Aged; Aorta, Abdominal; Aortic Aneurysm; Chronic Disease; Cyclohexanecarboxylic Acids; Disseminated | 1989 |
Effects of an inhibitor of angiotensin converting enzyme (Captopril) on pulmonary and renal insufficiency due to intravascular coagulation in the rat.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disseminated Intr | 1989 |
Tranexamic acid in the treatment of Kasabach-Merritt syndrome in infants.
Topics: Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Fema | 1989 |
[Treatment of severe coagulopathy in the Kasabach-Merritt syndrome].
Topics: Adult; Cyclohexanecarboxylic Acids; Disseminated Intravascular Coagulation; Female; Hemangioma; Huma | 1986 |
Effect of N-acetylcysteine on fibrin deposition in the rat lung due to intravascular coagulation.
Topics: Acetylcysteine; Animals; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Humans; Iodine | 1986 |
[Disseminated intravascular coagulation as a complication of shock].
Topics: Aminocaproic Acid; Aprotinin; Disseminated Intravascular Coagulation; Heparin; Humans; Shock; Tranex | 1973 |